Medical Review Criteria Guidelines for Managed Care 12th edition 2013

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • Nov 2014

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. Indeed, the chronic heart failure agent is believed to represent both a significant growth drive ...

Industries: Pathology | Countries: United States

Arrhythmia Research Technology, Inc.

Arrhythmia Research Technology, Inc.

  • $ 55
  • Company report
  • by Wright Investors' Service
  • November 2014
  • 56 pages

A textual analysis of the financial results for Arrhythmia Research Technology, Inc. compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses and up to 10-year history of sales, earnings, dividends and security pricing. ...

Industries: Pathology

Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

Anthera Pharmaceuticals‚ Inc. (Symbol:ANTH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Anthera Pharmaceuticals‚ Inc. SWOT Analysis report provides you ...

Industries: Pathology | Countries: United States

BB BIOTECH AG (Symbol:BION) SWOT Analysis, Strategy, Revenues and Profits

BB BIOTECH AG (Symbol:BION) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. BB BIOTECH AG SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States, Switzerland

BioRx, LLC SWOT Analysis, Strategy, Revenues and Profits

BioRx, LLC SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

Genoptix, Inc. (Symbol:GXDX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Genoptix, Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: United States

Ina Research Inc. (Symbol:2176) SWOT Analysis, Strategy, Revenues and Profits

Ina Research Inc. (Symbol:2176) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Ina Research Inc. SWOT Analysis report provides you a strategic analysis ...

Industries: Pathology | Countries: Philippines, Japan

Prana Biotechnology Limited (Symbol:PBT) SWOT Analysis, Strategy, Revenues and Profits

Prana Biotechnology Limited (Symbol:PBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Prana Biotechnology Limited SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: United States

Daiichi Sankyo, Inc. SWOT Analysis, Strategy, Revenues and Profits

Daiichi Sankyo, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: United States

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Sunshine Biopharma, Inc. SWOT Analysis report provides you a strategic ...

Industries: Pathology | Countries: Canada

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 339 368 6001

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.